ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 503,27
-2,66%
Dow Jones
38 589,16
-0,15%
DAX
18 002,02
-1,43%
Brent Oil
82,275
0,00%
Bitcoin
66 091,32
-0,15%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. PRA Health Sciences Inc (PRAH)

  7. PRA Health Sciences Inc (PRAH) Actualités

PRAH

PRA Health Sciences (PRAH)

PRA Health Sciences Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:PRAH
DateHeureSourceTitreSymboleSociété
02/02/202218h50Edgar (US Regulatory)Schedule 13gNASDAQ:PRAHPRA Health Sciences Inc
13/07/202112h02Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(b) (15-12b)NASDAQ:PRAHPRA Health Sciences Inc
12/07/202122h27Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:PRAHPRA Health Sciences Inc
12/07/202116h23Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:PRAHPRA Health Sciences Inc
02/07/202100h30Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PRAHPRA Health Sciences Inc
01/07/202115h49Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:PRAHPRA Health Sciences Inc
01/07/202115h39Edgar (US Regulatory)Post-effective Amendment to an Automatic Shelf Registration of Form S-3asr or Form F-3asr (posasr)NASDAQ:PRAHPRA Health Sciences Inc
01/07/202114h57Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PRAHPRA Health Sciences Inc
30/06/202118h28Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:PRAHPRA Health Sciences Inc
29/06/202100h07PR Newswire (US)DT Midstream Set to Join S&P MidCap 400NASDAQ:PRAHPRA Health Sciences Inc
23/06/202114h01Business WireVeradigm and PRA Health Sciences Partner to Create the Industry’s Leading EHR-Based Clinical Research NetworkNASDAQ:PRAHPRA Health Sciences Inc
14/06/202115h28Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:PRAHPRA Health Sciences Inc
26/05/202113h00GlobeNewswire Inc.Anavex Life Sciences Announces Appointment of Ms Jiong Ma, PhD to Board of DirectorsNASDAQ:PRAHPRA Health Sciences Inc
13/05/202122h02GlobeNewswire Inc.PRA Health Sciences pioneers connecting clinical trial patients with their real-world data with SynomaNASDAQ:PRAHPRA Health Sciences Inc
28/04/202122h01GlobeNewswire Inc.PRA Health Sciences, Inc. Reports First Quarter 2021 ResultsNASDAQ:PRAHPRA Health Sciences Inc
28/04/202112h07Edgar (US Regulatory)Proxy Statement - Merger or Acquisition (definitive) (defm14a)NASDAQ:PRAHPRA Health Sciences Inc
21/04/202122h02GlobeNewswire Inc.PRA Health Sciences expands its response to COVID-19 with pharmacovigilance solutions for authorized vaccines and therapeutic...NASDAQ:PRAHPRA Health Sciences Inc
13/04/202122h02GlobeNewswire Inc.PRA Health Sciences selected by Maryland State Medical Society to supply remote patient monitoring and telehealth servicesNASDAQ:PRAHPRA Health Sciences Inc
07/04/202122h01GlobeNewswire Inc.PRA’s remote patient monitoring platform selected by Merck KGaA, Darmstadt, Germany to work in combination with its human g...NASDAQ:PRAHPRA Health Sciences Inc
30/03/202123h20Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:PRAHPRA Health Sciences Inc
22/03/202121h01GlobeNewswire Inc.PRA’s Center for Rare Diseases Launches Toolkit to Identify and Mitigate Risks to Rare Disease Clinical ProgramsNASDAQ:PRAHPRA Health Sciences Inc
25/02/202113h11TipRanksPRA Health Sciences To Be Acquired By ICON For $12B; Shares Pop 19%NASDAQ:PRAHPRA Health Sciences Inc
24/02/202117h59Edgar (US Regulatory)Annual Report (10-k)NASDAQ:PRAHPRA Health Sciences Inc
24/02/202112h04GlobeNewswire Inc.PRA Health Sciences, Inc. Reports Fourth Quarter and Full Year 2020 ResultsNASDAQ:PRAHPRA Health Sciences Inc
24/02/202112h00Business WireICON to Acquire PRA Health Sciences, Creating a World Leader in Healthcare Intelligence and Clinical ResearchNASDAQ:PRAHPRA Health Sciences Inc
04/02/202119h00GlobeNewswire Inc.PRA Health Sciences to Report Fourth Quarter and Full Year 2020 EarningsNASDAQ:PRAHPRA Health Sciences Inc
17/12/202022h02GlobeNewswire Inc.PRA Health Sciences collaborates with PWNHealth and Fulgent Genetics to provide at-home COVID-19 test capabilitiesNASDAQ:PRAHPRA Health Sciences Inc
19/11/202022h02GlobeNewswire Inc.PRA Health Sciences appoints senior FDA official to lead new Global Center of Excellence for Decentralized Clinical Trial Str...NASDAQ:PRAHPRA Health Sciences Inc
05/11/202019h01Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:PRAHPRA Health Sciences Inc
04/11/202022h01GlobeNewswire Inc.PRA Health Sciences, Inc. Reports Third Quarter 2020 Results and Updates Full Year 2020 GuidanceNASDAQ:PRAHPRA Health Sciences Inc
 Showing the most relevant articles for your search:NASDAQ:PRAH

Dernières Valeurs Consultées

EU
PX1
CAC 40
NASDAQ
AAPL
Apple
COIN
ETHUSD
Ethereum
EU
ORA
Orange
NYSE
KO
Coca Cola
EU
RI
Pernod Ricard
EU
RNO
Renault
EU
CAP
Capgemini
NYSE
DIS
Walt Disney
EU
DG
Vinci
NASDAQ
GOOGL
Alphabet
EU
BEL20
Bel 20
EU
HO
Thales
EU
BNP
BNP Paribas
FTSE
UKX
FTSE 100
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés